When Cure Means Control: An introduction to viral control off therapy

As the number of cure-related clinical trials grows, so does the number of people experiencing month-long delays in viral rebound. A very small handful of participants remain off therapy long after the trial ends. These individuals who can control HIV without therapy after an intervention are known as controllers.

This webinar will:
-Introduce the concept of viral control off therapy
-Provide a platform to ask experts questions on HIV control
-Introduce key issues advocates should be following

Featuring Jon LI, Harvard University; Marina Caskey, Rockefeller University; Ann Chahroudi, Emory School of Medicine, Josephine Nabukenya, EGPAF Board Member and IAS Governing Council Member, and moderated by Jessica Salzwedel, AVAC